THEVAX GENETICS VACCINE CO LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.5 TWD | +40.63% |
|
+177.78% | -.--% |
| 1 day | +40.63% |
| Managers | Title | Age | Since |
|---|---|---|---|
Yao Chun Chou
DFI | Director of Finance/CFO | - | - |
Hsueh Han Chang
BRD | Director/Board Member | - | - |
Chun Wei Lin
AUD | Comptroller/Controller/Auditor | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiu Chi Chang
BRD | Director/Board Member | - | 15-06-25 |
Jui Chen Tsai
BRD | Director/Board Member | - | 14-06-25 |
Hsueh Han Chang
BRD | Director/Board Member | - | - |
Thevax Genetics Vaccine Co Ltd is a Taiwan-based company mainly engaged in provision of biotechnological services. The Company is mainly engaged in research and development of human vaccines. The Company's main products include therapeutic monovalent vaccines TVGV-1 and multivalent vaccines TVGV-2 of cervical cancer and precancerous lesions, and therapeutic vaccines TVGV-3 of Hepatitis B.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 13.32M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 6567 Stock
